Literature DB >> 21427073

Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type.

Helmut Hopfer1, Thorsten Wiech, Michael J Mihatsch.   

Abstract

BACKGROUND: Renal amyloidosis results from protein misfolding and leads to progressive renal insufficiency. Few data are available concerning the relevance of the histomorphological patterns and the dynamics of the disease process.
METHODS: Cases of renal amyloidosis in native kidney biopsies (n = 203) were retrospectively evaluated for the pattern of amyloid distribution, the extent of glomerular amyloid deposition and the amount of interstitial fibrosis and tubular atrophy. One hundred and fifty-eight cases were characterized by immunohistochemistry to determine the biochemical amyloid type. Morphological findings were correlated with available clinical data.
RESULTS: According to the predominant site of amyloid deposition, 84.6% showed a glomerular, 9.4% a vascular and 6% a tubulointerstitial distribution pattern. Within the glomeruli, amyloid was initially deposited in a focal segmental fashion that became diffuse and global in later stages. Most cases were identified as AL lambda (84/158) or AA (68/158). There was no correlation between the biochemical type and the distribution pattern. Serum creatinine correlated well with interstitial fibrosis and tubular atrophy and proteinuria with the glomerular amyloid load.
CONCLUSIONS: The relevance of the different distribution patterns is unclear at the moment, but they may be due to the physicochemical properties of the amyloid fibrils in a given patient. This may become important in future anti-fibrillar therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21427073     DOI: 10.1093/ndt/gfq831

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

Review 1.  Anesthetic modulation of neuroinflammation in Alzheimer's disease.

Authors:  Junxia X Tang; Maryellen F Eckenhoff; Roderic G Eckenhoff
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

2.  Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.

Authors:  Masatoyo Ozawa; Atsushi Komatsuda; Hiroshi Ohtani; Mizuho Nara; Ryuta Sato; Masaru Togashi; Naoto Takahashi; Hideki Wakui
Journal:  Clin Exp Nephrol       Date:  2016-04-26       Impact factor: 2.801

Review 3.  [Causes and treatment of systemic amyloidosis].

Authors:  N Blank; U Hegenbart; S Schönland
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 4.  Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature review.

Authors:  Xianrui Dou; Haitang Hu; Yongle Ju; Yongdong Liu; Kaifu Kang; Shufeng Zhou; Wenfang Chen
Journal:  Diagn Pathol       Date:  2011-10-13       Impact factor: 2.644

5.  Clinical Presentation of Tubulointerstitial Nephritis Caused by Amyloid Light-chain Amyloidosis in a Patient with Sjögren's Syndrome.

Authors:  Reiko Inoue; Yoshihide Fujigaki; Kana Kobayashi; Yoshifuru Tamura; Tatsuru Ota; Shigeru Shibata; Tsuyoshi Ishida; Fukuo Kondo; Yutaka Yamaguchi; Shunya Uchida
Journal:  Intern Med       Date:  2017-02-15       Impact factor: 1.271

6.  Correlation between amyloid deposits affecting renal compartments and glomerular filtration rate during renal biopsy in a renal amyloidosis case series.

Authors:  E O Fonseca; M L R Caldas; P J Soares Filho; J R Almeida
Journal:  Braz J Med Biol Res       Date:  2020-05-18       Impact factor: 2.590

7.  Distribution of amyloid deposits in the kidneys of a patient with reactive amyloidosis associated with rheumatoid arthritis.

Authors:  Takeshi Kuroda; Naohito Tanabe; Hiroe Sato; Takeshi Nakatsue; Yoko Wada; Shuichi Murakami; Masaaki Nakano; Ichiei Narita
Journal:  BMC Res Notes       Date:  2013-06-14

8.  Percentage of urinary albumin excretion and serum-free light-chain reduction are important determinants of renal response in myeloma patients with moderate to severe renal impairment.

Authors:  H Sugihara; D Chihara; K Seike; K Fukumoto; M Fujisawaa; Y Suehara; Y Nishida; M Takeuchi; K Matsue
Journal:  Blood Cancer J       Date:  2014-08-01       Impact factor: 11.037

Review 9.  Proteomics and mass spectrometry in the diagnosis of renal amyloidosis.

Authors:  Maria M Picken
Journal:  Clin Kidney J       Date:  2015-09-11

10.  Revisiting renal amyloidosis with clinicopathological characteristics, grading, and scoring: A single-institutional experience.

Authors:  Abhiram Kalle; Archana Gudipati; Sree Bhushan Raju; Karthik Kalidindi; Swarnalatha Guditi; Gangadhar Taduri; Megha S Uppin
Journal:  J Lab Physicians       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.